Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,046,701
Percent of class
6.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-020719
Form type
SC 13G/A
Filer
BRANDES INVESTMENT PARTNERS, LP
CIK
CIK 1015079
Filed
Feb 11, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub